Business Wire

CA-AGENDIA

6.1.2022 21:43:03 CET | Business Wire | Press release

Share
Agendia Appoints Suja Chandrasekaran and Scott Mendel to Board of Directors, Strengthening Advisory Group to Support Company Momentum

Agendia, Inc. , a commercial stage company focused on precision oncology for breast cancer, today announced the appointment of healthcare industry veterans Suja Chandrasekaran, MS and Scott Mendel, MBA to the Company’s Board of Directors.

“We are pleased to be expanding Agendia’s Board of Directors with the appointment of two accomplished industry executives,” said Mark Straley, Chief Executive Officer of Agendia. “With combined decades of leadership and results-driven performance, Suja and Scott will provide Agendia with invaluable guidance, informed by extensive executive experience. As we continue to deliver on our goal to provide crucial genomic information to physicians and their patients to improve care, we look forward to tapping into their diverse expertise.”

“Suja’s reputation for growing, scaling, and transforming global businesses with data-driven go-to-market strategies and business vision is unparalleled,” said Patrick J. Balthrop, Chairman of the Board at Agendia. “Similarly, Scott’s executive insights and deep financial experience will be integral assets as we position the business for ongoing operational excellence and commercialization to best serve the breast cancer community.”

Suja Chandrasekaran, MS

Ms. Chandrasekaran joins Agendia’s Board with over 25 years of experience in building businesses in retail, consumer, manufacturing, and healthcare. Her specialties include risk management, ESG, and the employment of digital capabilities to drive growth and revenue. Ms. Chandrasekaran currently serves as Senior Executive Vice President, Chief Digital and Information Officer at CommonSpirit Health, where she leads the digitization of healthcare focusing on unleashing the power of data with AI to provide rich patient and provider experiences. Previously she was the Global Chief Technology Officer at Walmart Inc. and Kimberly-Clark Corporation. She also serves on the boards of American Eagle Outfitters and Blume Global Technologies.

Ms. Chandrasekaran earned her Master of Business Systems at Monash University in Melbourne, Australia and her Bachelors in Electrical Engineering from the University of Madras, India. She holds many prestigious honors recognizing her technology and digital leadership, including her recent induction into the CIO Hall of Fame.

“Agendia is harnessing impressive science to deliver state-of-the-art solutions to the breast cancer community and I’m honored to contribute to the company’s meaningful mission,” said Chandrasekaran. “I am especially excited by the technology supporting MammaPrint and BluePrint genomic tests as well as the potential future expansion into next generation sequencing and digital AI pathology solutions to follow the patient throughout her journey.”

Scott Mendel, MBA

Mr. Mendel is an industry veteran with over 25 years in public and private corporate leadership, notably in healthcare, software, and diagnostics. Most recently, Mr. Mendel served as the Chief Executive Officer of GenMark Diagnostics, overseeing a period of rapid growth and the process that ultimately led to the company’s purchase by Roche Diagnostics. Mr. Mendel previously served as GenMark’s Chief Operating Officer and Chief Financial Officer, leveraging his deep expertise in finance and manufacturing scale-up, fund raising and investor relations, and general commercial operations and strategy.

Prior to GenMark, Mr. Mendel held senior-level leadership positions with The Active Network and GE Healthcare. He serves as Audit Committee Chair and Compensation Committee member at Akoya Biosciences and is a member of Board of Advisors at Specific Diagnostics and Visby Medical. He holds a Bachelor of Science in finance from Indiana University and a Master of Business Administration from Northwestern University’s Kellogg School of Management.

“I am thrilled to join Agendia’s Board of Directors and to partner with the impressive, mission-driven genomic specialists, operational talent, and industry leaders in our shared vision,” said Mendel. “I look forward to contributing my executive expertise as Agendia pursues its objectives to advance genomic testing in breast cancer and improve outcomes for patients.”

The Agendia Board and management team is committed to bringing in and utilizing strong executive and operational talent at all levels to align with the superior execution and focus on propelling the Company’s advancement in all areas. We believe this dedication translates into exceptional science, actionable and transformative research, and bringing innovative new products to market to ensure breast cancer patients, their families and their physicians have access to the information they need to make the best decisions about the treatment journey. Learn more here .

About Agendia

Agendia is a mission-driven company focused on enabling optimized decision-making by providing physicians with next-generation diagnostic and information solutions that can be used to help improve outcomes for breast cancer patients worldwide. The company currently offers two commercially-available genomic profiling tests that help surgeons, oncologists and pathologists to personalize treatment for women at critical intervention points throughout their patient journey.

MammaPrint® is a 70-gene prognostic test that, along with other clinicopathologic factors, determines a specific patient’s breast cancer recurrence risk. BluePrint® is an 80-gene molecular subtyping test that identifies the underlying biology of an individual breast cancer to provide information about its behavior, long-term prognosis and potential response to systemic therapy. Together, MammaPrint® and BluePrint® provide a holistic view of an individual patient’s breast cancer, enabling physicians to objectively select the best treatment plan.

For more information on Agendia’s assays and ongoing trials, please visit www.agendia.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ant International’s Alipay+ and The New York Liberty Celebrate Season of Sustainability Impact on Community, Environmental and Youth Empowerment16.11.2026 05:08:00 CET | Press release

The first-season partnership delivers tangible results: 219 trees planted, 650 pairs of shoes donated, and youth empowered through inaugural Math Hoops tournament Ant International’s Alipay+, a leading cross-border fintech services platform, and the WNBA’s New York Liberty, today announced the results of their joint sustainability initiatives for the season. Marking the first season of the multi-year collaboration, Alipay+ and the New York Liberty planted a total of 219 trees — one for every three-pointer made by the New York Liberty and Alipay+ in-game fan contestants during home games at Barclays Center this season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261115082353/en/ Students celebrate during the inaugural Liberty NBA Math Hoops Regional Tournament. In addition to the on-court tree-planting pledge, the partners concluded their fan-driven Sneaker Drive, collecting 650 pairs of shoes to support environmental cons

VELOCIFERO Takes Action Against Counterfeiting in China13.11.2026 17:32:00 CET | Press release

White s.r.o., exclusive owner of the VELOCIFERO brand, takes action in China to protect its intellectual property rights. Initial measures in Chongqing and Taizhou have already resulted in the seizure of vehicles alleged to be counterfeit. VELOCIFERO is taking action against counterfeiting in China. White s.r.o., the exclusive owner of the VELOCIFERO brand and its related intellectual property rights, has launched decisive measures to protect its creative and industrial assets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261113797570/en/ Photo courtesy of White s.r.o. “Vehicle sealed in Chongqing as part of actions undertaken to protect VELOCIFERO’s intellectual property rights.” The matter originated in June 2026 when, according to the company’s complaint, computers were removed from the technical office of Taizhou Siweiluo, the company appointed to manufacture VELOCIFERO products. White s.r.o. subsequently became aware

LangChain Raises $300M to Enable Every Company to Own Their Intelligence13.11.2026 16:53:00 CET | Press release

CapitalG leads Series C funding round at a $3B valuation to advance LangChain's agent engineering platform LangChain today announced it has raised $300 million in new funding at a $3 billion valuation, bringing total funding to date to $460 million. The round was led by existing investor CapitalG, with significant participation from new investors GIC and DFJ Growth and existing investors IVP and Sapphire Ventures. LangChain is advancing its mission to help every company own its intelligence. As agents transform the economy, companies are building domain-specific agents differentiated by their knowledge, data, and user experience. These agents will power new products and transform internal company operations, creating lasting competitive advantages for the companies that control them. "Agents are going to transform how companies operate and the products they deliver. The companies that control these systems will build lasting competitive advantages," said Harrison Chase, Co-Founder and

Kinaxis Named a Leader in Five 2026 IDC MarketScapes for Worldwide Supply Chain Planning13.11.2026 13:00:00 CET | Press release

Maestro delivers concurrent planning on a single platform across discrete, process, consumer packaged goods and life sciences Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, today announced it has been named a Leader in five 2026 IDC MarketScape vendor assessments for worldwide supply chain planning. The recognition spans the overall market and four industries - discrete industries, process industries, consumer packaged goods and life sciences industries - all served by a single platform, Kinaxis Maestro®, the company's AI-powered supply chain orchestration platform. "Supply chain leaders don't need a better forecast once a month. They need to know what changed this morning, what it means across the business, and what to do about it," said Andrew Bell, Chief Product Officer of Kinaxis. "I believe being named a Leader across five IDC MarketScape vendor assessments, in industries that plan in very different ways, shows that a single concurr

SBC Medical Announces Capital and Business Alliance with NeuroBrain Dynamics to Advance Clinic Profitability Through Medical AI13.11.2026 12:30:00 CET | Press release

Companies to co-develop six medical AI solutions targeting revenue expansion and cost reduction; SBC Medical secures priority sales rights in Japan and South Korea and targets B2B expansion across Asia SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced a strategic capital and business alliance agreement with NeuroBrain Dynamics Inc. (“NBD”), a Taipei-based company dedicated to enterprise generative AI solutions. As part of the agreement executed on November 13, 2026, SBC Medical has made a minority equity investment in NBD. Through this alliance, SBC Medical plans to introduce two complementary suites of generative AI solutions across its network of 287 clinics in Japan and overseas*: “revenue-growth AI,” to elevate average revenue per visit and customer retention through personalized customer guidance, and “cost-reduction AI,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye